Maravai LifeSciences
MRVI
MRVI
195 hedge funds and large institutions have $4.77B invested in Maravai LifeSciences in 2021 Q2 according to their latest regulatory filings, with 80 funds opening new positions, 74 increasing their positions, 34 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
26% more call options, than puts
Call options by funds: $4.18M | Put options by funds: $3.31M
1.8% less ownership
Funds ownership: 101.79% → 100% (-1.8%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
195
Holding in Top 10
2
Calls
$4.18M
Puts
$3.31M
Top Buyers
| 1 | +$135M | |
| 2 | +$125M | |
| 3 | +$123M | |
| 4 |
OCBV
Ownership Capital B.V.
Amsterdam,
Netherlands
|
+$97.2M |
| 5 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$72.9M |
Top Sellers
| 1 | -$127M | |
| 2 | -$68.5M | |
| 3 | -$48.3M | |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$41.3M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
-$28M |